Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New steroidal lactones from M. crassissima disclosed by PharmaMar

Nov. 23, 2011

Bendamustine evaluated in anaplastic glioma

Nov. 23, 2011

Cabozantinib trial begins in hormone receptor-positive breast cancer

Nov. 22, 2011

Merrimack Pharmaceuticals begins enrollment in MM-121/erlotinib combination trial

Nov. 22, 2011

FDA approves Erwinaze for acute lymphoblastic leukemia

Nov. 22, 2011

Maximum tolerated dose of LDE-225 determined in patients with solid tumors

Nov. 22, 2011

FDA reaches final decision on Avastin for metastatic breast cancer

Nov. 21, 2011

Mologen's phase I/II study of cell-based renal cancer therapy meets primary endpoint

Nov. 21, 2011

AstraZeneca receives positive CHMP opinion for vandetanib

Nov. 21, 2011

NCI commences phase I trial of AZD-7451 for gliomas

Nov. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...